【产品名称】千层塔提取物
【英文名称】Huperzia Serrate P.E.
【产品别名】金不换、虱子草、宝塔花
【提取部位】为石松科石杉属植物蛇足石杉Lycopodium serratum Thunb.，以全草入药。
【产品规格】石杉碱甲 10：1
【产品性状】白色粉末 / 棕色粉末
【产品包装】内用双层塑料袋1公斤铝箔，外用纸板桶（25公斤/桶）
【保存方法】置于阴凉干燥、避光，避高温处。
【保 质 期】两年
【产品名称】千层塔提取物 （CAS No.: 102518-79-6）
【英文名称】Huperzia Serrate P.E.
【拉丁名称】Huperzia serratum
【 植物来源】石杉科石杉属植物蛇足石杉
【 产品外观】棕色至白色粉末
【有效成分】石杉碱甲
【规格】Huperzine A1％--99％
【分子量】 242.32
【分子式】C15H18N2O
【熔点】 230℃旋光度: -150.4°
【溶解性】易溶于氯仿，溶于 、乙醇，微溶于水
【检测方法】HPLC
【工艺流程】 原料→乙醇提取→浓缩→浸膏→溶剂萃取→萃取液→浓缩浸膏→喷雾干燥→粉碎、混合、包装→产品
【药理作用】石杉碱甲是一种乙酰胆碱酯酶的可逆抑制剂，具有选择性高、毒性低和药效时间长等特点，是目前为止国际上治疗老年痴呆较为理想的候选 。用于重症肌无力、老年性记忆衰退和早老性痴呆症、青少年学习障碍和记忆增强。
[Product name] Melaleuca extract
[English name] Huperzia Serrate P.E.
[Product alias] Gold not change, lice grass, pagoda flower
【 Extracted part 】 It was Lycopodium serratum Thunb. Whole grass was used as medicine.
【 Product Specification 】 Huperzine A 10:1
[Product properties] White powder/brown powder
[Product packaging] Internal double plastic bag 1 kg aluminum foil, external cardboard bucket (25 kg/bucket)
[Storage method] Store in a cool and dry place, away from light and high temperature.
[Warranty period] Two years
[Product name] Melaleuca Extract (CAS No.: 102518-79-6)
[English name] Huperzia Serrate P.E.
Huperzia serratum
【 Plant source 】 A plant belonging to the genus Huperia of the family Huperia
[Product appearance] Brown to white powder
[Active ingredient] huperzine A
【 Specification 】Huperzine A1 % -- 99%
【 Molecular weight 】 242.32
【 Molecular formula 】C15H18N2O
【 Melting point 】 230℃ rotation: -150.4°
[Solubility] Soluble in chloroform, soluble in ethanol, slightly soluble in water
[Detection method] HPLC
[Process flow] Raw material → ethanol extraction → concentration → extract → solvent extraction → extract liquid → concentrate extract → spray drying → grinding, mixing, packaging → Product
[Pharmacological action] Huperzine A is a reversible inhibitor of acetylcholinesterase, which has the characteristics of high selectivity, low toxicity and long efficacy, and is so far an ideal candidate for the treatment of Alzheimer's disease in the world. For myasthenia gravis, senile memory decline and Alzheimer's disease, adolescent learning disabilities and memory enhancement.
|
